brain disease: A disease affecting the brain or part of the brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
190 |
4. Check minimum number of eventsNone |
190 |
5. Include endpointsNone |
190 |
6. Filter based on genotype QC (FinnGen only) |
190 |
Control definitions (FinnGen only)
- Control exclude
- G6_HYDROCEPH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Hydrocephalus in other diseases
based on the number of shared cases.
Similar with more cases:
- Hydrocephalus
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1769 | 924 | 839 |
| Only index persons | 1488 | 795 | 693 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 56.83 | 58.92 | 54.41 |
| Only index persons | 57.38 | 58.88 | 55.66 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 190 | 120 | 70 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 60.27 | 59.94 | 60.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 174
- Matched controls
- 1737
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
1230.7
116.5
101
*
AAF00
NOMESCO Finland
Ventriculostomy
477.3
101.4
92
*
AA1AD
NOMESCO Finland
CT of head and brain
20.2
66.6
132
234
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
14.1
46.5
91
125
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
45.9
42
*
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
+∞
43.6
40
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
97.2
41.2
44
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
16.0
38.1
66
64
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
36.8
34
*
ZXD05
NOMESCO Finland
Urgent procedure
8.1
35.6
111
309
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
90.0
33.3
36
5
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
31.2
29
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
+∞
30.1
28
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
97.0
29.9
32
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
+∞
27.9
26
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
26.8
25
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
303.5
26.5
26
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
303.5
26.5
26
*
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
289.9
25.4
25
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
145.0
24.3
25
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
9.3
24.2
54
80
K90
ICPC
Stroke/cerebrovascular accident
35.9
23.7
30
10
PA2AD
NOMESCO Finland
CT angiography of brain
75.8
23.6
26
*
AA5PD
NOMESCO Finland
CT examination of brain pefusion
45.2
22.5
27
7
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
250.1
22.1
22
*
N03AX14
ATC
levetiracetam; systemic
23.9
21.3
30
15
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
+∞
20.2
19
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.9
19.9
84
278
WX730
NOMESCO Finland
Conventional respirator
39.4
19.5
24
7
G942, I602
ICD-10 Finland
NA
+∞
19.1
18
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
211.9
18.9
19
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
18.1
18.8
29
19
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
18.0
17
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.9
17.6
55
127
WX872
NOMESCO Finland
Intensive care
11.2
16.3
31
33
AA1AA
NOMESCO Finland
Head X-ray examination
66.4
16.1
18
*
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
14.8
14
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
19.2
14.7
22
13
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
163.1
14.7
15
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
10.3
14.7
29
33
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
20.3
13.7
20
11
XX3DW
NOMESCO Finland
Time consuming IT work
5.9
13.5
40
84
H02AB02
ATC
dexamethasone; systemic
5.5
13.4
42
95
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
26.7
12.7
17
7
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
12.4
12.4
22
20
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
12.4
11.9
21
19
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
20.7
11.8
17
9
R51.80
ICD-10 Finland
Headache
4.2
11.7
49
149
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
16.6
11.6
18
12
G942, I615
ICD-10 Finland
NA
+∞
11.6
11
*
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
11.6
11
*
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
+∞
11.6
11
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
128.1
11.6
12
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
128.1
11.6
12
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
21.9
11.4
16
8
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
19.4
11.0
16
9
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
17.5
10.6
16
10
G942, I601
ICD-10 Finland
NA
+∞
10.5
10
*
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
10.5
10
*
G94.1
ICD-10 Finland
Hydrocephalus in neoplastic disease
+∞
10.5
10
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
7.3
10.2
24
37
N18
ICPC
Paralysis/weakness
13.3
10.1
17
14
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
18.1
10.1
15
9
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
105.5
9.5
10
*
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
105.5
9.5
10
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
+∞
9.5
9
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
9.5
9
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
+∞
9.5
9
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
14.8
9.4
15
11
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
16.8
9.2
14
9
SPAT1229
SPAT
Assessment of need for aid
5.1
9.1
29
66
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
9.1
69
322
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
25.6
9.0
12
5
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.0
8.4
27
62
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
8.4
8
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
15.5
8.3
13
9
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
12.7
7.7
13
11
PA7BD
NOMESCO Finland
CT angiography of neck and brain
10.8
7.7
14
14
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.8
7.7
14
14
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
26.3
7.7
10
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
26.3
7.7
10
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.2
7.6
43
163
N29
ICPC
Neurological sympt/complt other
14.2
7.5
12
9
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.6
7.4
13
12
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.3
7.4
27
71
G941, D431
ICD-10 Finland
NA
+∞
7.3
7
*
G942, I690
ICD-10 Finland
NA
+∞
7.3
7
*
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
+∞
7.3
7
*
G942, I600
ICD-10 Finland
NA
+∞
7.3
7
*
G942, I609
ICD-10 Finland
NA
+∞
7.3
7
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
7.3
7
*
N03AF02
ATC
oxcarbazepine; oral
8.5
7.3
15
19
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.5
7.3
15
19
ZXC86
NOMESCO Finland
Use of endoscopic device
31.4
7.2
9
*
D21
ICPC
Swallowing problem
12.8
7.2
12
10
WX882
NOMESCO Finland
High dependency care
6.9
7.1
17
27
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
7.1
66
336
SPAT1231
SPAT
Assessment of adjustments needed in living environment
14.6
7.0
11
8
Z2221
NOMESCO Finland
Medical doctor
0.2
6.9
10
363
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
6.9
83
484
D33.30
ICD-10 Finland
Acoustic neuroma
41.7
6.8
8
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
23.6
6.7
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
9.3
6.7
13
15
SPAT1216
SPAT
Assessment of functional ability
3.1
6.6
38
145
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
15.0
6.5
10
7
NK6AI
NOMESCO Finland
Other cone beam scan
72.4
6.5
7
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
72.4
6.5
7
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
72.4
6.5
7
*
K91
ICPC
Cerebrovascular disease
18.9
6.3
9
5
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
6.3
6
*
G942, I606
ICD-10 Finland
NA
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
I60.5
ICD-10 Finland
Subarachnoid haemorrhage from vertebral artery
+∞
6.3
6
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
6.3
6
*
L28
ICPC
Limited function/disability (L)
2.9
6.1
40
164
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
7.7
6.0
13
18
Z3231
NOMESCO Finland
Registered nurse
0.2
6.0
9
326
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
73
12
98.17
136.68
3.7
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
75
29
42.08
113.94
3.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
60
10
87.23
111.10
3.2
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
45
41
14.07
44.12
2.5
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
35
6
70.93
31.32
3.9
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
130
625
4.42
21.27
6.6
8.8
inr
1.1
1.2
2.41
58
189
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
26
8
37.32
20.80
2.6
1.0
%
55.8
—
—
16
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
125
599
4.18
20.20
3.9
3.9
ng/l
40.0
32.6
0.18
101
414
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
55
157
4.52
18.17
4.2
3.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
58
6.43
17.63
1.5
2.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
23
30
8.58
16.94
2.8
2.8
%
18.1
15.0
—
9
11
(3023368) Bacteria identified in Blood by Culture
90
401
3.36
15.09
4.3
4.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
29
56
5.93
14.91
1.6
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
22
35
6.98
13.61
6.4
3.1
mmol/l
2.8
2.6
0.13
12
22
(40761536) Microorganisms panel - Urine sediment
43
133
3.89
12.41
6.1
3.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
15
17
9.49
12.17
3.1
1.2
mosm/kgh2o
284.5
277.1
0.42
15
12
(3013512) EKG study
95
485
2.92
11.90
3.7
4.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
141
918
3.08
10.77
7.2
5.1
mmol/l
6.5
6.6
0.23
136
852
(3009343) pH of Capillary blood
35
103
3.94
10.76
6.9
4.6
ph
7.4
7.4
—
8
10
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
34
99
3.96
10.60
6.7
4.8
mmol/l
2.3
1.5
0.56
28
74
(3021901) Oxygen saturation in Capillary blood
15
25
6.43
8.79
3.9
2.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
38
138
3.19
8.42
13.1
7.4
mmol/l
6.4
9.6
3.14
38
131
(3044640) Blood type and Crossmatch panel - Blood
88
499
2.42
8.13
4.4
2.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
31
5.54
8.08
6.4
2.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
80
441
2.41
7.80
5.7
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
80
3.61
7.42
7.6
4.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
13
8.06
7.19
3.6
1.7
ug/l
22.9
18.1
—
10
13
(3019225) pH of Specimen
37
145
2.93
7.14
4.5
5.1
—
—
—
0
0
(4035726)
38
159
2.74
6.47
1.5
1.4
—
—
—
0
0
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
6
0
+∞
6.28
5.7
0.0
ug/l
0.1
—
—
6
0
(3021440) Promyelocytes/100 leukocytes in Blood
32
125
2.88
6.18
4.9
5.0
%
0.2
0.2
0.05
18
40
(3029937) Albumin [Presence] in Urine by Test strip
71
407
2.19
6.02
6.3
4.0
estimate
0.0
0.0
0.00
36
147
(3017181) Myelocytes/100 leukocytes in Blood
33
138
2.68
5.60
4.8
4.7
%
1.4
0.8
0.76
18
46
(3000850) Epithelial cells [#/volume] in Urine
60
333
2.17
5.44
4.6
2.5
e6/l
7.6
5.1
0.81
55
290
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
48
243
2.30
5.43
1.9
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
47
236
2.32
5.41
2.3
2.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
105
721
2.02
5.33
6.3
4.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
177
2.43
5.16
1.9
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
135
1596
0.47
4.99
4.8
5.1
mmol/l
2.6
2.8
0.74
118
1460
(3026008) Bacteria identified in Urine by Culture
76
476
1.99
4.91
5.2
3.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
62
367
2.02
4.65
4.7
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
139
1085
2.05
4.58
6.6
4.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
66
407
1.95
4.37
1.8
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
27
116
2.55
4.33
7.2
2.6
e9/l
4.1
3.8
0.23
21
93
(3002179) Metamyelocytes/100 leukocytes in Blood
28
123
2.50
4.29
3.9
4.8
%
1.5
0.5
1.40
11
33
(3031040) Bacteria [#/volume] in Urine by Automated count
132
1024
1.95
4.28
7.3
4.3
e6/l
181.6
247.4
—
10
17
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
88
600
1.87
4.27
6.4
3.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
14
6.69
4.03
3.7
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
108
796
1.83
4.00
10.7
7.6
mmol/l
1.2
1.2
0.07
75
671
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
134
1563
0.52
3.93
4.6
4.5
mmol/l
1.4
1.5
1.10
118
1430
(3002385) Erythrocyte distribution width [Ratio]
108
1341
0.55
3.90
26.4
17.6
%
13.8
13.8
0.09
108
1323
(3025159) Blasts/100 leukocytes in Blood
27
122
2.41
3.89
5.2
4.9
%
0.0
0.2
0.49
13
36
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
26
4.00
3.57
1.2
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
26
4.00
3.57
1.2
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
26
4.00
3.57
1.2
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
26
4.00
3.57
1.1
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
26
4.00
3.57
1.2
1.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
6
10.27
3.52
2.2
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
99
732
1.74
3.45
9.3
6.7
mmol/l
1.2
1.2
0.09
89
662
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
125
1474
0.56
3.44
6.9
5.7
mmol/mol
40.2
40.0
0.12
110
1364
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
27
3.85
3.40
1.2
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
32
3.59
3.39
6.2
3.2
%
51.5
60.7
1.09
11
32
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
32
3.59
3.39
4.2
2.7
e9/l
4.3
5.1
0.20
11
32
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
14
5.91
3.37
1.3
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
137
1572
0.54
3.37
4.6
4.5
mmol/l
4.5
4.7
1.16
119
1450
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
7
8.80
3.28
1.5
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
7
8.80
3.28
1.2
10.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
56
357
1.81
3.22
7.1
5.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
119
2.27
3.22
2.2
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
52
327
1.81
3.12
1.4
1.9
pmol/l
514.6
473.1
0.28
40
263
(3044889) 12 lead EKG panel
85
1095
0.60
3.08
4.3
3.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
79
563
1.69
3.05
6.8
5.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
492
1.71
3.04
5.8
3.0
e6/l
27.6
189.2
0.66
65
380
(3011397) Hemoglobin [Presence] in Urine by Test strip
16
346
0.41
3.01
7.9
3.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
22
4.24
2.92
1.4
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
124
1446
0.59
2.87
16.8
15.1
%
37.1
39.9
1.14
50
1059
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
108
844
1.65
2.86
10.6
6.5
umol/l
8.1
10.7
4.63
102
806
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
6
8.51
2.76
2.8
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.51
2.76
1.6
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
81
2.35
2.63
1.3
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
38
3.01
2.63
1.6
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
25
3.73
2.61
1.3
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
82
2.32
2.57
1.9
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
7
7.30
2.56
6.2
3.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
45
2.78
2.50
2.7
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
21
3.93
2.49
1.1
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
34
3.05
2.45
2.1
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
97
760
1.56
2.40
6.2
3.7
estimate
0.0
0.0
0.00
39
152
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
17
4.23
2.38
3.4
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
155
1688
0.56
2.34
14.7
10.7
u/l
28.6
25.8
1.13
146
1623
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
69
502
1.59
2.34
2.9
2.4
u/l
46.9
56.2
2.56
62
464
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
23
3.58
2.29
5.3
3.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
23
3.58
2.29
2.9
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
62
442
1.60
2.28
3.1
3.3
ng/l
632.6
1114.3
1.94
54
368
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
75
564
1.54
2.17
5.5
3.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
43
2.65
2.13
1.4
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
436
0.56
2.12
9.6
6.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
97
775
1.51
2.10
6.3
3.7
estimate
0.0
0.0
0.00
39
145
(3035941) MCH [Entitic mass]
165
1759
0.53
2.09
38.0
20.7
pg
30.2
30.2
0.02
160
1734
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
303
0.48
2.09
1.8
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
50
2.49
2.07
4.9
4.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
768
1.51
2.06
7.8
5.0
estimate
0.0
0.0
0.00
38
149
(44790048)
7
21
3.42
1.98
1.4
1.9
—
—
—
0
0
(44790047)
7
21
3.42
1.98
1.4
1.9
—
—
—
0
0
(44790049)
7
21
3.42
1.98
1.4
1.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
21
3.42
1.98
1.7
2.1
—
—
—
0
0
(44806118)
7
21
3.42
1.98
1.4
1.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
135
1506
0.64
1.95
4.5
4.0
mmol/l
1.3
1.3
0.38
121
1369
(3018095) Leukocytes [#/volume] in Urine
75
575
1.50
1.95
7.5
3.7
e6/l
75.3
69.7
0.05
68
410
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
267
0.49
1.86
2.8
2.7
e6/l
1.1
1.0
—
9
150
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
17
3.61
1.85
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
30
2.74
1.74
2.0
2.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
48
0.00
1.72
0.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
30
447
0.61
1.71
1.7
1.7
mmol/l
1.3
1.4
0.15
20
376
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
216
1.64
1.69
4.2
4.5
%
32.7
32.0
0.16
26
144
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
31
2.65
1.68
3.6
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
25
2.87
1.66
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
41
287
1.55
1.59
2.0
1.7
nmol/l
1309.8
1239.6
0.18
33
215
(1761868) Lipid panel - Serum or Plasma
69
538
1.44
1.59
3.4
3.0
—
—
—
0
0
(4094501)
0
45
0.00
1.52
0.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
21
2.92
1.52
1.7
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
84
997
0.72
1.44
2.6
3.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
6
22
2.78
1.44
12.0
3.4
u/ml
48.7
82.7
—
6
22
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
46
2.24
1.42
3.2
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
53
2.14
1.41
2.0
2.5
—
—
—
0
0
(3000492) Spirometry study
7
147
0.46
1.39
1.0
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
23
2.66
1.38
2.5
3.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
5
17
2.99
1.36
1.0
1.4
nmol/l
—
0.3
—
0
10
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
0
38
0.00
1.36
0.0
1.1
—
17.5
—
0
6
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
18
2.82
1.29
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
18
2.82
1.29
1.0
1.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
93
786
1.36
1.28
7.6
5.7
%
60.7
56.7
2.47
88
736
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
144
1554
0.70
1.26
4.4
4.6
mmol/l
6.0
5.9
0.41
121
1417
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
25
2.44
1.25
1.7
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
315
0.63
1.21
3.9
4.4
%
22.8
22.3
0.06
11
148
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
26
2.35
1.19
1.8
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
40
2.04
1.13
1.8
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
21
2.42
1.09
1.0
1.6
pg
32.2
32.6
—
5
21
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
32
2.23
1.09
12.1
2.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
8
147
0.52
1.09
24.4
11.1
g/l
117.8
119.6
—
8
140
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
22
2.31
1.04
1.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
53
1.94
1.03
3.0
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
221
0.60
1.01
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
23
2.20
0.98
2.6
2.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
115
1028
1.30
0.98
4.9
3.2
u/l
64.2
46.8
0.71
107
969
(3014051) Protein [Presence] in Urine by Test strip
0
31
0.00
0.97
0.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
354
1.36
0.95
2.2
1.8
mg/l
0.6
1.3
3.50
37
279
(3026493) Urate [Moles/volume] in Serum or Plasma
32
418
0.72
0.92
3.3
3.0
umol/l
350.6
8128.8
2.51
27
356
(3000330) Specific gravity of Urine by Test strip
13
79
1.69
0.90
5.2
3.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
25
181
1.44
0.85
13.8
20.1
inr
1.1
1.3
—
8
22
(3015736) pH of Urine
71
609
1.26
0.80
5.4
3.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
133
0.58
0.77
1.1
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
94
838
1.24
0.75
7.6
5.7
e9/l
1.7
2.1
1.48
89
751
(3013139) Helicobacter pylori Ag [Presence] in Stool
6
109
0.54
0.75
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
58
490
1.26
0.74
5.2
4.2
ph
7.4
7.4
1.34
33
96
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
26
1.95
0.71
3.8
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
11
167
0.64
0.69
18.8
10.2
kpa
17.2
12.1
0.83
11
160
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
11
167
0.64
0.69
18.8
10.1
kpa
5.0
5.2
0.65
11
160
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
133
1237
1.25
0.69
10.9
7.7
u/l
83.6
81.6
0.13
124
1158
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
22
291
0.72
0.69
2.8
3.4
ng/l
1732.0
126.8
0.44
12
226
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
140
1482
0.79
0.69
5.4
4.8
mu/l
1.8
2.8
0.63
119
1338
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
42
1.69
0.69
1.7
1.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
113
1222
0.81
0.67
5.1
4.1
mm/h
13.1
12.3
0.20
102
1114
(3022145) Colonoscopy Study observation
13
187
0.67
0.65
1.3
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
91
818
1.22
0.64
7.2
5.6
e9/l
0.6
0.6
0.08
85
715
(3001122) Ferritin [Mass/volume] in Serum or Plasma
59
676
0.82
0.61
3.6
2.7
ug/l
167.8
114.9
0.80
49
623
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
196
0.69
0.61
2.1
6.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.1
—
3.5
—
0
10
(21494890) Protein electrophoresis panel - 24 hour Urine
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
20
0.00
0.60
0.0
1.1
—
7.3
—
0
11
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
10
148
0.66
0.57
19.8
8.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
61
1.50
0.54
1.3
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
9
62
1.47
0.54
9.8
12.1
%
1.7
1.6
—
9
57
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
31
376
0.79
0.54
1.3
1.3
u/ml
0.8
1.9
—
9
99
(3030467) Casts [#/volume] in Urine by Automated count
52
451
1.21
0.52
5.3
2.9
e6/l
0.3
0.5
0.58
46
339
(3006315) Basophils [#/volume] in Blood
90
821
1.18
0.52
7.4
5.6
e9/l
0.0
0.0
1.25
84
719
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
45
1.58
0.49
1.0
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
45
1.58
0.49
2.0
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
154
0.70
0.49
1.3
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
285
0.78
0.48
1.3
1.3
u/ml
1.4
13.1
—
7
104
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
116
0.68
0.47
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
120
0.65
0.47
2.1
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
620
0.84
0.47
1.9
1.9
pmol/l
107.6
97.6
0.67
38
297
(3013115) Eosinophils [#/volume] in Blood
92
848
1.16
0.45
7.6
5.9
e9/l
0.2
0.2
0.54
86
758
(3008152) Bicarbonate [Moles/volume] in Arterial blood
6
92
0.64
0.43
14.8
11.6
mmol/l
25.5
24.7
—
6
84
(40761511) CBC panel - Blood by Automated count
161
1659
0.81
0.43
28.0
13.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
33
1.53
0.41
1.2
1.4
—
3.2
—
0
7
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.53
0.41
2.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
301
0.80
0.41
1.3
1.3
iu/ml
75.2
30.0
—
7
112
(3011648) Oxygen content in Venous blood
0
15
0.00
0.41
0.0
2.1
—
11.6
—
0
15
(4281824)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
13
170
0.75
0.40
3.1
1.9
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
3.3
—
25.0
—
0
5
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
154
1486
1.19
0.38
21.8
13.4
ml/min/173m2
85.7
80.7
2.36
140
1204
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
8
115
0.68
0.38
2.4
2.3
ng/l
143.6
173.1
—
8
105
(36304419) Bacteria [Presence] in Urine
49
436
1.17
0.37
5.1
2.9
—
—
—
0
0
(4010399)
9
125
0.71
0.36
1.2
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
73
671
1.14
0.36
2.7
2.4
nmol/l
80.2
77.8
0.24
66
598
(3020682) Albumin/Creatinine [Ratio] in Urine
53
477
1.15
0.35
3.6
4.0
mg/mmol
5.0
7.8
0.40
31
289
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
47
1.29
0.32
2.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
345
0.85
0.32
2.1
1.5
g/l
2.5
2.5
0.05
20
191
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
99
0.70
0.31
10.6
3.7
mmol/l
24.1
23.9
—
7
94
(3015377) Calcium [Moles/volume] in Serum or Plasma
61
559
1.13
0.31
3.6
3.4
mmol/l
2.3
2.4
0.42
53
485
(3048689) Calprotectin [Mass/mass] in Stool
17
206
0.81
0.31
2.4
1.8
ug/g
379.4
114.3
—
7
161
(3009508) Creatinine [Moles/volume] in Urine
45
496
0.88
0.28
4.0
3.1
mmol/l
6.2
7.4
1.10
34
410
(3025941) Bacteria identified in Stool by Culture
12
96
1.27
0.25
1.2
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
82
0.72
0.24
29.3
15.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
16
134
1.21
0.23
1.5
2.3
ug/l
8.3
5.2
0.24
11
116
(3024561) Albumin [Mass/volume] in Serum or Plasma
72
677
1.10
0.23
7.6
4.6
g/l
33.1
35.8
2.74
63
640
(3037522) Nuclear Ab [Titer] in Serum
19
220
0.85
0.23
1.4
1.4
titre
226.7
439.2
—
6
49
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
177
0.83
0.22
1.5
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
42
1.20
0.21
17.2
17.7
mmol/l
1.3
1.1
—
5
36
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
28.9
—
0
11
(3004451) EKG impression Narrative
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.5
—
—
—
0
0
(3016750) Collection duration of Urine
0
10
0.00
0.21
0.0
2.7
—
499.2
—
0
5
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
12.5
—
0
10
(3047189) Immunofixation for 24 hour Urine
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
12
0.00
0.21
0.0
1.4
—
64.6
—
0
7
(3004775) Volume in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.8
—
673.8
—
0
5
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
793.5
—
0
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
494.0
—
0
8
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
42.5
—
0
8
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
295.9
—
0
8
(4146454)
0
14
0.00
0.20
0.0
3.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
11
90
1.24
0.19
8.7
9.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
142
0.83
0.18
2.7
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
70
672
1.07
0.13
1.9
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
167
0.89
0.11
2.7
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
40
380
1.07
0.10
1.5
1.5
nmol/l
18.3
21.8
0.73
31
312
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
369
0.94
0.09
2.4
2.2
mg/l
3.8
3.3
0.46
30
319
(3020891) Body temperature
6
58
1.04
0.08
4.7
4.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
62
0.80
0.08
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
11
98
1.13
0.08
3.5
2.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
70
0.85
0.08
1.5
3.2
u/ml
6.7
2073.6
—
6
61
(3024354) Oxygen [Partial pressure] in Venous blood
16
147
1.10
0.07
6.4
3.2
kpa
4.2
4.5
0.54
16
142
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
255
0.93
0.07
1.5
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
123
1242
0.97
0.03
5.1
4.0
pmol/l
15.5
14.8
2.06
107
1126
(3033658) Prothrombin time (PT) actual/Normal
39
401
0.97
0.03
5.8
3.5
%
91.8
92.9
0.11
39
392
(3012516) Albumin [Mass/volume] in Urine
44
451
0.97
0.03
2.6
3.3
mg/l
130.5
49.0
0.40
24
277
(3019832) Treponema pallidum Ab [Presence] in Serum
10
92
1.09
0.03
2.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
128
0.93
0.02
2.6
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
198
0.96
0.02
1.8
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
14
134
1.05
0.00
5.2
2.8
g/l
9.5
9.5
0.02
14
121
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
160
1594
1.02
0.00
27.7
14.2
mg/l
18.8
22.2
0.75
147
1228
(3004588) Protein electrophoresis panel - Serum or Plasma
10
101
0.99
0.00
1.6
2.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
103
0.97
0.00
4.9
3.1
u/ml
46.8
44.2
—
10
97
(46235355) HIV 1 and 2 tests - Meaningful Use set
23
233
0.99
0.00
1.8
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
53
0.94
0.00
1.4
4.3
—
3.8
—
0
6
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
28.6
—
0
9
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
200
1.00
0.00
1.8
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
9.0
—
0
7
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
75
0.93
0.00
2.3
2.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3020491) Glucose [Moles/volume] in Blood
0
7
0.00
0.00
0.0
3.0
—
6.8
—
0
7
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4198724)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
87
0.92
0.00
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
10.7
—
0
6
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.9
—
53.4
—
0
9
(3017704) Immunofixation for Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
7
78
0.89
0.00
17.4
10.3
mmol/l
24.2
24.8
—
7
73
(3036071) Salmonella sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
5.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
10.0
—
1.2
—
0
6
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002256) Pathology report gross observation
20
200
1.00
0.00
1.4
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HCINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCINOTH | 5.144 [3.85, 6.87] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.055 |
During the follow-up period (1.1.1998 — 31.12.2019), 238 out of 716 females with G6_HCINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HCINOTH | 5.443 [3.94, 7.52] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.055 |
During the follow-up period (1.1.1998 — 31.12.2019), 203 out of 639 males with G6_HCINOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_HCINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.386% | 0.987% |
| 5 | 3.0% | 6.198% |
| 10 | 6.745% | 15.626% |
| 15 | 12.709% | 27.03% |
| 20 | 20.651% | 42.374% |
Relationships between endpoints
↥Index endpoint: G6_HCINOTH – Hydrocephalus in other diseases
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data